Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
three
months ended in Jun. 2026,
Elliptic Laboratories ASA paidkr0.0 Mil more to buy back shares than it received from issuing new shares.
It receivedkr0.0 Mil from issuing more debt.
It paidkr0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.
It receivedkr0.0 Mil from paying cash dividends to shareholders.
It spentkr3.6 Mil on other financial activities.
In all, Elliptic Laboratories ASAspentkr3.6 Mil on financial activities for the
three
months ended in Jun. 2026.
Elliptic Laboratories ASA (OSL:ELABS) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
Elliptic Laboratories ASA's issuance of stock for the
three
months ended in Jun. 2026 was kr0.0 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
Elliptic Laboratories ASA's repurchase of stock for the
three
months ended in Jun. 2026 was kr0.0 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
Elliptic Laboratories ASA's net issuance of debt for the
three
months ended in Jun. 2026 was kr0.0 Mil.
Elliptic Laboratories ASA receivedkr0.0 Mil from issuing more debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
Elliptic Laboratories ASA's net issuance of preferred for the
three
months ended in Jun. 2026 was kr0.0 Mil.
Elliptic Laboratories ASA paidkr0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Elliptic Laboratories ASA's cash flow for dividends for the
three
months ended in Jun. 2026 was kr0.0 Mil.
Elliptic Laboratories ASA receivedkr0.0 Mil from paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
Elliptic Laboratories ASA's other financing for the
three
months ended in Jun. 2026 was kr-3.6 Mil.
Elliptic Laboratories ASA spentkr3.6 Mil on other financial activities.
Elliptic Laboratories ASA Cash Flow from Financing Related Terms
Elliptic Laboratories ASA Cash Flow from Financing Historical Data
* Premium members only.
The historical data trend for Elliptic Laboratories ASA's Cash Flow from Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elliptic Laboratories ASA Cash Flow from Financing Chart
Elliptic Laboratories ASA Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Elliptic Laboratories ASA's Cash from Financing for the fiscal year that ended in Dec. 2025 is calculated as:
Cash Flow from Financing for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr48.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow from Financing of kr48.0 Mil mean?
Elliptic Laboratories ASA (OSL:ELABS) has a Cash Flow from Financing of kr48.0 Mil as of Jun. 2026. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Elliptic Laboratories ASA and its competitors.
Is Elliptic Laboratories ASA's Cash Flow from Financing too high?
Elliptic Laboratories ASA's current Cash Flow from Financing is kr48.0 Mil. Overall, Elliptic Laboratories ASA has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Elliptic Laboratories ASA's Cash Flow from Financing compare to MSFT and PLTR?
Elliptic Laboratories ASA's Cash Flow from Financing of kr48.0 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for a Software company?
A good Cash Flow from Financing depends on the Software industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Elliptic Laboratories ASA and its competitors. Elliptic Laboratories ASA's current Cash Flow from Financing is kr48.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elliptic Laboratories ASA stock overvalued right now?
Based on GuruFocus' analysis, Elliptic Laboratories ASA (OSL:ELABS) is currently considered Possible Value Trap. The stock's GF Value™ is kr10.09, compared to a current price of kr3.73 — trading 63% below its estimated fair value. The current Cash Flow from Financing is kr48.0 Mil. Elliptic Laboratories ASA's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For Elliptic Laboratories ASA (OSL:ELABS), the current Cash Flow from Financing is kr48.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elliptic Laboratories ASA (OSL:ELABS) Overvalued in 2026?
Based on GuruFocus' analysis, Elliptic Laboratories ASA stock appears to be undervalued.
The current stock price of kr3.73 is trading 63% below its estimated GF Value™ of kr10.09.
GuruFocus considers Elliptic Laboratories ASA to be Possible Value Trap.
Key valuation signals for OSL:ELABS:
Cash Flow from Financing: kr48.0 Mil
GF Value™: kr10.09 vs. price of kr3.73 (63% below fair value)
No single metric tells the full story. See the OSL:ELABS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Elliptic Laboratories ASA develops and sells technical solutions that enable the interaction and information exchanges between individuals and technical devices, based on ultrasound software technology. Such devices include mobile phones, IoT devices, and other devices that could deploy the group's software technology to enhance the user experience. Its patented artificial intelligence (AI) software platform combines ultrasound and sensor fusion algorithms to deliver intuitive proximity, presence, and gesture sensing experiences. Its scalable AI Virtual Smart Sensor Platform creates software-only sensors that are sustainable, eco-friendly, and already deployed in hundreds of millions of devices around the world.
76GF Score
Get the complete analysis for OSL:ELABS
Cash Flow from Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:ELABS has been successfully added to your 
